NGL Fine Chem Reports Mixed Financial Results Amid Cash Flow Growth and Profit Decline in August 2025

NGL Fine Chem, a microcap player in the Pharmaceuticals & Biotechnology industry, has recently reported its financial results for the quarter ending June 2025. The results, declared on August 1, 2025, indicate a notable adjustment in evaluation, with the score shifting to -7 from -14 over the past three months. The financial data reveals some positive aspects for NGL Fine Chem. The company achieved its highest operating cash flow in three years, amounting to Rs 35.82 crore, reflecting a robust generation of cash revenues from its business operations. Additionally, net sales reached Rs 104.19 crore for the quarter, marking the highest figure in the last five quarters, suggesting a favorable near-term sales trend. Conversely, there are significant challenges highlighted in the financial results. The profit after tax (PAT) for the latest six months stands at Rs 9.78 crore, showing a substantial decline of 54.60% year on year. Furthermore, non-operating income constitutes 53.63% of profit before tax, indicating a reliance on income from non-business activities, which raises concerns about sustainability. For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.